Evidence map›Paper›PMID 26844205›Full record

ArticleMolecular metabolism2016

Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.

Mark Nixon, Randi Stewart-Fitzgibbon, Jingqi Fu, Dmitry Akhmedov, Kavitha Rajendran, Maria G Mendoza-Rodriguez, Yisel A Rivera-Molina, Micah Gibson, Eric D Berglund, Nicholas J Justice and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mark NixonDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Randi Stewart-FitzgibbonDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA; Program in Cell and Regulatory Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston TX 77030, USA.
Jingqi FuDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Dmitry AkhmedovDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Kavitha RajendranDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Maria G Mendoza-RodriguezDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Yisel A Rivera-MolinaDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Micah GibsonDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA.
Eric D BerglundAdvanced Imaging Research Center and Department of Pharmacology, University of Texas Southwestern Medical School, USA.
Nicholas J JusticeInstitute of Molecular Medicine Center for Metabolic and Degenerative Diseases, University of Texas Health Science Center, Houston, TX 77030, USA; Program in Cell and Regulatory Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston TX 77030, USA.
Rebecca BerdeauxDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX 77030, USA; Institute of Molecular Medicine Center for Metabolic and Degenerative Diseases, University of Texas Health Science Center, Houston, TX 77030, USA; Program in Cell and Regulatory Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston TX 77030, USA.
The University of Texas Health Science Center at Houston · USUniversity of Houston · USAdvanced Imaging Research (United States) · US

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Diabetes Endocrinology Research CenterP30DK079638 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 2008 to 2012
$6.4M
Task Specific Project 4U54CA136404 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SEVICK, EVA M. · 2008 to 2012
$5.1M
Regulation of glucose utilization by skeletal muscle SIK1R01DK092590 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BERDEAUX, REBECCA L · 2011 to 2021
$3.3M
SHORT TERM RESEARCH TRAININGT35DK007676 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KONE, BRUCE C. · 1992 to 2017
$1.8M
The role of SIK1 in myogenic differentiation and skeletal muscle repairR01AR059847 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BERDEAUX, REBECCA L · 2011 to 2015
$1.7M
Central and Endocrine Stress Pathway Contributions to Alzheimers DiseaseK01AG036738 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JUSTICE, NICHOLAS J · 2010 to 2013
$502k
NCATS NIH HHS UL1 TR000371NCI NIH HHS U54 CA136404NIAMS NIH HHS R01 AR059847NIA NIH HHS K01 AG036738NIDDK NIH HHS P30 DK056338NIDDK NIH HHS P30 DK057521NIDDK NIH HHS P30 DK079638NIDDK NIH HHS R01 DK092590NIDDK NIH HHS T35 DK007676
6 · The paper itself

Abstract

objectiveInsulin resistance causes type 2 diabetes mellitus and hyperglycemia due to excessive hepatic glucose production and inadequate peripheral glucose uptake. Our objectives were to test the hypothesis that the proposed CREB/CRTC2 inhibitor salt inducible kinase 1 (SIK1) contributes to whole body glucose homeostasis in vivo by regulating hepatic transcription of gluconeogenic genes and also to identify novel SIK1 actions on glucose metabolism.

methodsWe created conditional (floxed) SIK1-knockout mice and studied glucose metabolism in animals with global, liver, adipose or skeletal muscle Sik1 deletion. We examined cAMP-dependent regulation of SIK1 and the consequences of SIK1 depletion on primary mouse hepatocytes. We probed metabolic phenotypes in tissue-specific SIK1 knockout mice fed high fat diet through hyperinsulinemic-euglycemic clamps and biochemical analysis of insulin signaling.

resultsSIK1 knockout mice are viable and largely normoglycemic on chow diet. On high fat diet, global SIK1 knockout animals are strikingly protected from glucose intolerance, with both increased plasma insulin and enhanced peripheral insulin sensitivity. Surprisingly, liver SIK1 is not required for regulation of CRTC2 and gluconeogenesis, despite contributions of SIK1 to hepatocyte CRTC2 and gluconeogenesis regulation ex vivo. Sik1 mRNA accumulates in skeletal muscle of obese high fat diet-fed mice, and knockout of SIK1 in skeletal muscle, but not liver or adipose tissue, improves insulin sensitivity and muscle glucose uptake on high fat diet.

conclusionsSIK1 is dispensable for glycemic control on chow diet. SIK1 promotes insulin resistance on high fat diet by a cell-autonomous mechanism in skeletal muscle. Our study establishes SIK1 as a promising therapeutic target to improve skeletal muscle insulin sensitivity in obese individuals without deleterious effects on hepatic glucose production.

Indexed as

AKT, protein kinase BAMPK, AMP-activated protein kinaseBAT, brown adipose tissuecAMP, cyclic adenosine monophosphateCHX, cycloheximideCREBCREB, cAMP response element-binding proteinCRTCCRTC, CREB regulated transcription coactivatorEndoRa, endogenous rate of glucose appearanceFGF21, fibroblast growth factor 21FOXO1, forkhead box protein O1FSK, forskolinG6pase, glucose 6-phosphataseGDR, glucose disposal rateGIR, glucose infusion rateGlgn, glucagonGluconeogenesisGlut, glucose transporterGTT, glucose tolerance testHDAC, histone deacetylaseHFD, high fat dietHSP, heat shock proteinIBMX, 3-isobutyl-1-methylxantineInsulin resistanceITT, insulin tolerance testPepck, phosphoenolpyruvate carboxykinasePgc, peroxisome proliferator-activated receptor gamma coactivatorPTT, pyruvate tolerance testSalt inducible kinaseSIK1SIK, salt inducible kinaseWAT, white adipose tissue

Identifiers

PMID26844205
PMCPMC4703802
OpenAlexW2107797142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.